1. Differential inhibition of mollicute growth: an approach to development of selective media for specific mollicutes.
- Author
-
Keçeli SA and Miles RJ
- Subjects
- Arginine analogs & derivatives, Arginine metabolism, Arginine pharmacology, Carbonyl Cyanide m-Chlorophenyl Hydrazone pharmacology, Drug Resistance, Bacterial, Energy Metabolism, Fluorides pharmacology, Indoleacetic Acids pharmacology, Ionophores pharmacology, Microbial Sensitivity Tests, Mycoplasma drug effects, Mycoplasma metabolism, Culture Media pharmacology, Dicyclohexylcarbodiimide pharmacology, Mycoplasma isolation & purification
- Abstract
The energy-generating pathways of Mycoplasma spp. are diverse. Thus, it was predicted that the ability of inhibitors of these pathways to block growth would vary among species. This prediction was tested with 14 Mycoplasma species and potential inhibitors. The greatest differentiation among test species was obtained using fluoride, iodoacetate (IAA), beta-fluoropyruvate (FP), cibacron blue (CB), L-citrulline, and carbonyl cyanide m-chlorophenylhydrazone. A range of other potential inhibitors, including L-arginine analogues, had little inhibitory effect on growth, and D-arginine was shown to be a growth substrate for arginine-hydrolyzing species. Fluoride selectively inhibited the growth of mycoplasmas that were able only to ferment sugars to lactate and/or to hydrolyze arginine. In contrast, IAA was most effective against organic acid-oxidizing species, and L-citrulline inhibited arginine-hydrolyzing species. Mycoplasma verecundum, a species for which energy sources have not been identified, was relatively resistant to FP. Similarly, Acholeplasma laidlawii was distinguished by its CB resistance.
- Published
- 2002
- Full Text
- View/download PDF